Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control

Diabetologia
J L Sánchez-QuesadaA de Leiva

Abstract

We evaluated the effect of improving glycaemic control with intensive insulin therapy on LDL susceptibility to oxidation, electronegative LDL proportion, and LDL subfraction phenotype in a group of 25 patients with short-duration insulin-dependent diabetes mellitus (IDDM); 25 matched healthy control subjects were also studied. LDL susceptibility to oxidation was measured by continuous monitoring of conjugated diene formation. Electronegative LDL was isolated by anion exchange chromatography, and quantified as percentage of total LDL. Six LDL subfractions were isolated by density gradient ultracentrifugation and phenotype A or B classified as the quotient (LDL1-LDL3)/(LDL4-LDL6). Compared to the control group, IDDM subjects with poor glycaemic control showed higher electronegative LDL (19.03 +/- 10.09 vs 9.59 +/- 2.98%, p < 0.001), similar LDL subfraction phenotype and lower susceptibility to oxidation (lag phase 45.6 +/- 8.8 vs 41.2 +/- 4.7 min, p < 0.05). After three months of intensive insulin therapy, HbA1c decreased from 10.88 +/- 2.43 to 5.69 +/- 1.54% (p < 0.001), and electronegative LDL to 13.84 +/- 5.15% (p < 0.05). No changes in LDL susceptibility to oxidation or LDL subfraction phenotype were observed. Electronegative...Continue Reading

Citations

Jun 27, 2001·Free Radical Biology & Medicine·T ParasassiF Ursini
Nov 17, 2001·European Journal of Internal Medicine·A M WägnerA Pérez
Jul 20, 2002·Trends in Molecular Medicine·Fulvio UrsiniAlex Sevanian
Sep 7, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·E MoroG B Bon
May 29, 2004·Current Opinion in Lipidology·José Luis Sánchez-QuesadaJordi Ordóñez-Llanos
Jun 12, 2004·Current Opinion in Clinical Nutrition and Metabolic Care·Ouliana Ziouzenkova, Jorge Plutzky
Jun 21, 2002·Annals of the New York Academy of Sciences·Fulvio Ursini, Alex Sevanian
Jul 22, 2010·Journal of Lipid Research·Cristina BancellsSònia Benítez
May 30, 2002·Biological Chemistry·Fulvio Ursini, Alex Sevanian
Sep 26, 2013·Mediators of Inflammation·Montserrat EstruchSònia Benítez
May 10, 2013·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·Mohammad Esmaeelinejad, Mohammad Bayat
Apr 8, 1999·Free Radical Research·R P Patel, V M Darley-Usmar
Apr 20, 2007·Biochimica Et Biophysica Acta·Sònia BenítezJose Luis Sánchez-Quesada
Oct 13, 2006·Atherosclerosis·Chao-yuh YangCharles V Smith
Jul 2, 2003·Diabetes Care·Roberto GambinoMaurizio Cassader
May 29, 2016·Biochimica Et Biophysica Acta·Montserrat EstruchSonia Benitez
Oct 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·C De CastellarnauJ Ordóñez-Llanos
Apr 25, 2006·Diabetes/metabolism Research and Reviews·Sónia BenítezJordi Ordóñez-Llanos
Nov 13, 2002·European Journal of Clinical Nutrition·L S AugustinC La Vecchia
Mar 31, 2018·Current Medicinal Chemistry·Andrea Rivas-UrbinaJosé Luis Sánchez-Quesada
Feb 23, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tiziana ParasassiFulvio Ursini
Jun 13, 2006·Arquivos brasileiros de endocrinologia e metabologia·Antonela F A SiqueiraSandra R G Ferreira
May 1, 2021·Journal of Clinical Medicine·Cristina ColomAntonio Pérez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.